C

Confluence Life Sciences, Inc.

3 employees

Confluence Life Sciences is focused on rational drug designs to develop novel kinase inhibitors for use in human and animal healthcare.

Basic info

Industry

research services

Sectors

Biotechnology
Health Care
Medical
Life Science

Date founded

2010

Funding rounds raised

Total raised

$4M

from 6 investors over 6 rounds

C

Confluence Life Sciences, Inc. raised $2.4M on July 28, 2015

Investors: St. Louis Arch Angels, Missouri Technology Corporation and Epidarex Capital

C

Confluence Life Sciences, Inc. raised $1M on February 19, 2014

Investors: Epidarex Capital

C

Confluence Life Sciences, Inc. raised $4M on September 17, 2012

Investors: Helix Funds

C

Confluence Life Sciences, Inc. raised $75K on April 1, 2011

Investors: Missouri Technology Corporation

FAQ